Kidswell Bio Corporation
TSE:4584
Kidswell Bio Corporation
Cost of Revenue
Kidswell Bio Corporation
Cost of Revenue Peer Comparison
Competitive Cost of Revenue Analysis
Latest Figures & CAGR of Competitors
Company | Cost of Revenue | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
---|---|---|---|---|---|
K
|
Kidswell Bio Corporation
TSE:4584
|
Cost of Revenue
-¥1.3B
|
CAGR 3-Years
-64%
|
CAGR 5-Years
-30%
|
CAGR 10-Years
-31%
|
GNI Group Ltd
TSE:2160
|
Cost of Revenue
-¥3.6B
|
CAGR 3-Years
-32%
|
CAGR 5-Years
-33%
|
CAGR 10-Years
-36%
|
|
PeptiDream Inc
TSE:4587
|
Cost of Revenue
-¥11.5B
|
CAGR 3-Years
-75%
|
CAGR 5-Years
-47%
|
CAGR 10-Years
N/A
|
|
Takara Bio Inc
TSE:4974
|
Cost of Revenue
-¥21.3B
|
CAGR 3-Years
-21%
|
CAGR 5-Years
-8%
|
CAGR 10-Years
-7%
|
|
Pharma Foods International Co Ltd
TSE:2929
|
Cost of Revenue
-¥13.1B
|
CAGR 3-Years
-38%
|
CAGR 5-Years
-49%
|
CAGR 10-Years
-35%
|
|
S
|
StemRIM Inc
TSE:4599
|
Cost of Revenue
N/A
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
See Also
What is Kidswell Bio Corporation's Cost of Revenue?
Cost of Revenue
-1.3B
JPY
Based on the financial report for Dec 31, 2023, Kidswell Bio Corporation's Cost of Revenue amounts to -1.3B JPY.
What is Kidswell Bio Corporation's Cost of Revenue growth rate?
Cost of Revenue CAGR 10Y
-31%
Over the last year, the Cost of Revenue growth was -74%. The average annual Cost of Revenue growth rates for Kidswell Bio Corporation have been -64% over the past three years , -30% over the past five years , and -31% over the past ten years .